Polymeric cryogels are biocompatible, and their biodegradation is independent of oxidative radicals

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 10, 2014, Pages 3409-3418

  Shakya, Akhilesh Kumar ^a,b   Holmdahl, Rikard ^b   Nandakumar, Kutty Selva ^b,c   Kumar, Ashok ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

^b Department of Biochemistry and Biophysics Medical Inflammation ResearchKarolinska Institute ^*  (Sweden)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

biocompatibility; cryogel; degradation; host tissue response; toxicity

Indexed keywords

BIOACTIVE GLASS; BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; BIODEGRADATION; DEGRADATION; HISTOLOGY; MACROPHAGES; MAMMALS; MICROBIOLOGY; PHEMA; TISSUE; TOXICITY;

CRYOGELS; HOST TISSUES; MACROPHAGE INFILTRATIONS; REACTIVE OXYGEN SPECIES; SUB-ZERO TEMPERATURES; SYSTEMIC TOXICITIES; TISSUE ENGINEERING APPLICATIONS; TUMOR NECROSIS FACTORS;

SCAFFOLDS (BIOLOGY);

ALGINIC ACID; GELATIN; GLASS; POLYMACON; POLYMER; POLYVINYL ALCOHOL; POLYVINYLCAPROLACTAM; RADICAL; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOMATERIAL; CRYOGEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; COMPOSITE MATERIAL; CONTROLLED STUDY; CRYOGEL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMPLANTATION; INBRED MOUSE STRAIN; MACROPHAGE; MOUSE; NONHUMAN; POLYMERIZATION; SYNTHESIS; TEMPERATURE; TISSUE ENGINEERING; TISSUE REACTION; TISSUE SPECIFICITY; TOXICITY TESTING; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; IMPLANT; KINETICS; OXIDATION REDUCTION REACTION; PHARMACOLOGY; SURFACE PROPERTY; TOXICITY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CRYOGELS; IMMUNOHISTOCHEMISTRY; IMPLANTS, EXPERIMENTAL; KINETICS; MACROPHAGES; MICE; OXIDATION-REDUCTION; POLYMERS; REACTIVE OXYGEN SPECIES; SURFACE PROPERTIES;

EID: 84896544198     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35013     Document Type: Article

References (43)

1. Langer R, Vacanti J,. Tissue engineering. Science 1993; 260: 920-926.
2. Vacanti J,. Tissue and organ engineering; can we build intestine and vital organs? J Gastrointest Surg 2003; 7: 831-835.
3. Skalak R, Fox CF,. Tissue engineering. In: Proc Workshop, Granlibakken, Lake Tahoe. New York: Liss; 1988. p 26-29.
4. Tamariz E, Rios-Ramírez A,. Biodegradation of medical purpose polymeric materials and their impact on biocompatibility. In:, Chamy R, Rosenkranz F, editors. Biodegradation-Life of Science. Croatia: Intech; 2013. p 1-29.
5. Anderson JM, Schoen FJ,. In vivo assessment of tissue biocompatibility. In:, Ratner BD, Hoffman AS, Schoen FJ, Lemons J, editors. Biomaterials Science. San Diego, CA: Academic Press; 1996. p 360.
6. Ratner BD, Hoffman AS, Schoen FJ, Lemons J,. Biomaterials Science. San Diego, CA: Academic Press; 1996.
7. Mikos AG, Sarakinos G, Leite SM, Vacanti JP, Langer R,. Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials 1993; 14: 323-330.
8. Mooney DJ, Mazzoni CL, Breuer C, McNamara K, Hern D, Vacanti JP,. Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials 1996; 17: 115-124.
9. Freed LE, Marquis JC, Nohria A, Emmanual J, Mikos AG, Langer R,. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res 1993; 27: 11-23.
10. Whang K, Thomas CH, Healy KE, Nuber G,. A novel method to fabricate bioabsorbable scaffolds. Polymer 1995; 36: 837-842.
11. Lo H, Ponticiello MS, Leong KW,. Fabrication of controlled release biodegradable foams by phase separation. Tissue Eng 1995; 1: 15-28.
12. Gomes ME, Ribeiro A, Malafaya PB, Reis RL, Cunha AM,. A new approach based on injection moulding to produce biodegradable starch based scaffolds. In: 25th Annual Meeting of the Society for Biomaterials, Providence, USA; 1999. p 224.
13. Sultana N, Wang M,. Fabrication of HA/PHBV composite scaffolds through the emulsion freezing/freeze-drying process and characterisation of the scaffolds. J Mater Sci Mater Med 2008; 19; 2555-2561.
14. Lu L, Mikos A,. The importance of new processing techniques in tissue engineering. MRS Bull 1996; 21: 28-32.
15. Huang Y, Onyeri S, Siewe M, Moshfeghian A, Madihally SV,. In vitro characterization of chitosan-gelatin scaffolds for tissue engineering. Biomaterials 2005; 26: 7616-7627.
16. Lozinsky V, Galaev I, Plieva F, Savina I, Jungvid H, Mattiasson B,. Polymeric cryogels as promising materials of biotechnological interest. Trends Biotechnol 2003; 21: 445-451.
17. Srivastava A, Shakya AK, Kumar A,. Boronate affinity chromatography of cells and biomacromolecules using cryogel matrices. Enzyme Microb Technol 2012; 51: 373-381.
18. Tripathi A, Kathuria N, Kumar A,. Elastic and macroporous agarose-gelatin cryogels with isotropic and anisotropic porosity for tissue engineering. J Biomed Mater Res Part A 2009; 90A: 680-694.
19. Kathuria N, Tripathi A, Kar KK, Kumar A,. Synthesis and characterization of elastic and Macroporous chitosan-gelatin cryogels for tissue engineering. Acta Biomater 2009; 5: 406-418.
20. Napoli A, Valentini M, Tirelli N, Müller M, Hubbell JA,. Oxidation-responsive polymeric vesicles. Nat Mater. 2004; 3: 183-189.
21. Yu SS, Koblin RL, Zachman AL, Perrien DS, Hofmeister LH, Giorgio TD, Sung HJ,. Physiologically relevant oxidative degradation of oligo(proline) cross-linked polymeric scaffolds. Biomacromolecules 2011; 12: 4357-4366.
22. Hultqvist M, Olofsson P, Holmberg J, Bäckström BT, Tordsson J, Holmdahl R,. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA 2004; 24; 101: 12646-12651.
23. Sareila O, Jaakkola N, Olofsson P, Kelkka T, Holmdahl R,. Identification of a region in p47phox/NCF1 crucial for phagocytic NADPH oxidase (NOX2) activation. Leukoc Biol 2013; 93: 427-435.
24. Singh D, Tripathi A, Nayak V, Kumar A., Three-dimensional proliferation of chondrocytes on modelled elastic and macroporous HEMA-gelatin cryogel. J Biomater Sci Polym Ed 2011; 22: 1733-1751.
25. Mishra R, Kumar A., Inorganic-organic biocomposite cryogels for regeneration of bony tissues. J Biomater Sci Polym Ed 2011; 22: 2107-2126.
26. Bhat S, Tripathi A, Kumar A,. Supermacroporous chitosan-agarose-gelatin cryogels: In vitro characterization and in vivo assessment for cartilage tissue engineering. J R Soc Interface 2010; 8: 540-554.
27. Srivastava A, Kumar A,. Synthesis and characterization of a temperature-responsive biocompatible poly(N-vinylcaprolactam) cryogel: A step towards designing a novel cell scaffold. J Biomater Sci Polym Ed 2009; 20: 1393-1415.
28. Anderson JM,. In vivo biocompatibility of implantable delivery systems and biomaterials. Eur J Pharm Biopharm 1994; 40: 1-8.
29. Giardino R, Rocca M, Fini M, Buscaroli S, Giavaresi G, Aldini NN, Bacchini P, Bertoni F,. Experimental evaluation in vitro and in vivo infection risk associated with the use of the most common sutures. Minerva Chir 1992; 47: 1799-1805.
30. Servan MA, Kaplan DL,. Silk. In:, Fisher JP, Mikos AG, Bronzino JD, Peterson DR, editors. Tissue Engineering: Principles and Practices. FL: Taylor and Francis group; 2012. p 2.4.
31. Cao Y, Wang B,. Biodegradation of silk biomaterials. Int J Mol Sci 2009; 10: 1514-1524.
32. Woodward SC,. Evaluation by light microscopy. In:, Von Recum AF, editor. Handbook of Biomaterials Evaluation: Scientific, Technical, and Clinical Testing of Implant Materials. Philadelphia: Taylor & Francis; 1999. p 599-612.
33. Anderson JM,. Inflammation and the foreign body response. Prob Gen Surg 1994; 11: 147-160.
34. Cotran RS, Kumar V, Robbins SL,. Inflammation and repair. In: Cotran, et al., editors. Pathologic Basis of Disease. Philadelphia: W.B. Saunders; 1994. p 51-92.
35. Bernatchez SF, Merkli A, Tabatabay C, Gurny R, Zhao QH, Anderson JM, Heller J,. Biotolerance of a semisolid hydrophobic biodegradable poly(ortho ester) for controlled drug delivery. J Biomed Mater Res 1993; 27: 677-681.
36. Beumer GJ, van-Blitterswijk CA, Ponec M,. Degradative behavior of polymeric matrices in (sub)dermal and muscle tissue of the rat: A quantitative study. Biomaterials 1994; 15: 551-559.
37. Holder Jr WD, Gruber HE, Moore AL, Culberson CR, Anderson W, Burg KJL, Mooney DJ,. Cellular ingrowth and thickness changes in poly- l -lactide and polyglycolide matrices implanted subcutaneously in the rat. J Biomed Mater Res 1998; 41: 412-421.
38. Hooper KA, Macon ND, Kohn J,. Comparative histological evaluation of new tyrosine-derived polymers and poly(l -lactic acid) as a function of polymer degradation. J Biomed Mater Res 1998; 41: 443-454.
39. Ratner BD,. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J Control Rel 2002; 78: 211-218.
40. Salzmann DL, Kleinert LB, Berman SS, Williams SK,. The effects of porosity on endothelialization of ePTFE implanted in subcutaneous and adipose tissue. J Biomed Mater Res 1997; 34: 463-476.
41. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM,. Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. J Biomed Mater Res 1998; 40: 586-597.
42. ® implantation: Host response and delivery of a potent analog of growth hormone-releasing factor. Int J Pharm 2002; 232: 119-129.
43. Sengupta S, Park SH, Seok GE, Patel A, Numata K, Lu CL, Kaplan DL,. Quantifying osteogenic cell degradation of silk biomaterials. Biomacromolecules 2010; 11: 3592-3599.